David W. Crabb, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 10,000 shares at $1.26 ($13K) on 2012-08-17, disclosed to the SEC on 2012-08-20.
Open-market purchase of $13k BASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.